CHINA PHARMA HOLDINGS, INC. (CPHI) › Operating IncomeCHINA PHARMA HOLDINGS, INC. (CPHI) — Operating IncomeAnnual figures by period end, from SEC filings.2010-12-31: $24.66M2011-12-31: $22.03M2012-12-31: $5.91M2013-12-31: -$18.61M2014-12-31: -$38.76M2015-12-31: -$14.30M2016-12-31: -$8.16M2017-12-31: -$18.68M2018-12-31: -$10.45M2019-12-31: -$20.41M2020-12-31: -$2.58M2021-12-31: -$2.86M2022-12-31: -$3.55M2023-12-31: -$2.75M2024-12-31: -$4.59M2025-12-31: -$3.24M-$3.24M2010-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$3.24M—2026-04-01From 2025-01-012024-12-31-$4.59M—2026-04-01From 2024-01-012023-12-31-$2.75M—2025-03-31From 2023-01-012022-12-31-$3.55M—2024-04-01From 2022-01-012021-12-31-$2.86M—2023-03-30From 2021-01-012020-12-31-$2.58M—2022-03-30From 2020-01-012019-12-31-$20.41M—2021-03-26From 2019-01-012018-12-31-$10.45M—2020-03-30From 2018-01-012017-12-31-$18.68M—2019-03-28From 2017-01-012016-12-31-$8.16M—2018-04-02From 2016-01-012015-12-31-$14.30M—2017-03-31From 2015-01-012014-12-31-$38.76M—2016-03-30From 2014-01-012013-12-31-$18.61M-415.1%2015-12-28From 2013-01-012012-12-31$5.91M-73.2%2014-03-20From 2012-01-012011-12-31$22.03M-10.7%2013-03-14From 2011-01-012010-12-31$24.66M—2012-03-14From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)